# Emami share price today (Emami Ltd, NSE: EMAMILTD)

> Emami share price today: ₹382.00 at the NSE close on 3 November 2026, down 28.5% in a year. Emami (NSE: EMAMILTD) is worth ₹16,663 crore, trades at a P/E of 22.0 and has closed between ₹359.75 and ₹539.55 over the past 52 weeks. > Emami Ltd's P/E is near the low end of its own history, higher than only 6% of past readings, and its quarterly results are still getting worse. EMAMILTD · FMCG - Personal Care · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/emami-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹382.00 (−28.5% in a year)
- P/E: 22.0× (lower than 94% of the last 11 years)
- Revenue (Jun 2026): ₹1,039 Cr (+14.9% on a year ago)
- Profit (Jun 2026): ₹139 Cr (−15.2% on a year ago)
- Operating margin: 22.0% (−1.0 points on a year ago)
- ROCE: 28%, FY26
- ROIC: 32.5%, against a 12.0% cost of capital: +20.5 points

The main question: the P/E is near the low end of its own history, higher than only 6% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the Emami share price today? Emami Ltd's share price was ₹382.00 at the close on 3 November 2026. It has been falling for 71 weeks. That is 10.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹360 and ₹540, and at that close it sat 12% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row. Over the last 11 years the share price moved −19% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What are Emami's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Emami reported revenue of ₹1,039 crore, up 14.9% from ₹904 crore a year earlier, and a profit of ₹139 crore, down 15.2% from ₹164 crore. ### Emami results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹1,039 crore | ₹904 crore | +14.9% |
| Profit | ₹139 crore | ₹164 crore | −15.2% |
| Earnings per share | ₹3.15 | ₹3.76 | −16.2% |
| Operating margin | 22.0% | 23.0% | −1.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Emami's management discussed these results on a call held on 4 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Emami share price history? Emami closed at ₹382.00 on 3 November 2026, down 28.5% from ₹534.40 a year earlier (31 October 2025) and down 32.2% over five years. Its highest weekly close since March 2016 was ₹832.70 on 6 September 2024. ### Emami share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹373.15 | +2.4% |
| 1 month ago · 1 Oct 2026 | ₹372.65 | +2.5% |
| 6 months ago · 30 Apr 2026 | ₹444.50 | −14.1% |
| 1 year ago · 31 Oct 2025 | ₹534.40 | −28.5% |
| 3 years ago · 3 Nov 2023 | ₹508.80 | −24.9% |
| 5 years ago · 4 Nov 2021 | ₹563.75 | −32.2% |
| 10 years ago · 4 Nov 2016 | ₹599.75 | −36.3% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹469.98 | −18.7% |
| Highest weekly close since March 2016 · 6 Sep 2024 | ₹832.70 | −54.1% |
| Lowest weekly close since March 2016 · 27 Mar 2020 | ₹156.40 | +144.2% |
| 52-week high (weekly close) · 12 Dec 2025 | ₹539.55 | −29.2% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹359.75 | +6.2% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (562 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Emami? 3 Nov 2026: Emami closed at ₹382.00, up 2.4% on the week and up 2.5% on the month. 4 Aug 2026: Emami held its results call for April to June 2026. Management guided: Further pricing actions to more than offset the absolute input-cost increase during the financial year; productivity, procurement, and value-led revenue management to support margins. ### Earlier

- Results for April to June 2026: Revenue up 14.9% and profit down 15.2% on a year earlier. - 10 Feb 2026: ex-date for an interim dividend of ₹6 a share. - 14 Nov 2025: ex-date for an interim dividend of ₹4 a share. ## What dividend does Emami pay? Emami paid ₹10 a share in regular dividends in the 12 months to 4 November 2026 (2 payments), a yield of 2.62% at the ₹382.00 close on 3 November 2026. The last was an interim dividend of ₹6 a share, ex-date 10 February 2026. ### Emami dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 10 Feb 2026 | ₹6 | Interim | same day |
| 14 Nov 2025 | ₹4 | Interim | same day |
| 22 May 2025 | ₹2 | Special | same day |
| 4 Feb 2025 | ₹4 | Interim | same day |
| 18 Nov 2024 | ₹4 | Interim | same day |
| 16 Feb 2024 | ₹4 | Interim | 19 Feb 2024 |
| 15 Nov 2023 | ₹4 | Interim | same day |
| 13 Feb 2023 | ₹4 | Interim | same day |
| 18 Nov 2022 | ₹4 | Interim | 21 Nov 2022 |
| 10 Feb 2022 | ₹4 | Interim | 11 Feb 2022 |
| 8 Nov 2021 | ₹4 | Interim | 9 Nov 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Emami Ltd paid out 56% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Emami management say on the latest results call? On the call for April to June 2026, held on 4 August 2026, Emami's management guided: Further pricing actions to more than offset the absolute input-cost increase during the financial year; productivity, procurement, and value-led revenue management to support margins. > “This is growing so quickly that it is hard for me to pinpoint. However, I think you would expect high-single-digit margins at the 3-year point, and then we will take it from there.”
> Dhruv Agarwal, on the call for April to June 2026

### What management guided

- Strategic treasury portfolio to reach ₹700-800 crore by FY27 year-end at 25-30% on a year earlier growth; operating margin expected at high-single-digit by the 3-year point. - International decline now considered over, with significant growth expected in Q3 and Q4 after business realignment. - Talc revenue expected to be substantially higher next reported quarter and significantly higher for the full year, recovering toward FY25 levels. - OTC business to sustain double-digit growth through the rest of the year. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/3559/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 4 August 2026.)

## What to watch in Emami's next results? When Emami reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Talc recovery toward the FY25 benchmark - check the next seasonal print for the expected normalization. - What to check (from the call)
- Talc recovery toward the FY25 benchmark - check the next seasonal print for the expected normalization. - India-origin OTC shipment approvals - check whether ministry clearance releases the backlog and restores international growth. - Consolidated margin recovery - check whether pricing offsets crude and packaging inflation as West Asia pressure eases. - Strategic portfolio profitability - check the next subsidiary disclosure for continued loss reduction from approximate break-even. ## Which stock lists is Emami on? Emami is on 3 of our India lists: 52 week high & low, Dividend stocks and Small & mid cap stocks. - [52 week high & low 52-week position: At 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)
- [Dividend stocks Regular dividend yield (%): 2.69](https://www.sectoralpha.in/dividend-stocks-india)
- [Small & mid cap stocks Size rank in India: 417](https://www.sectoralpha.in/small-cap-stocks-india)

## Is Emami profitable? Emami Ltd earned ₹139 Cr of net profit in the Jun 2026 quarter, −15.2% on the same quarter a year earlier. Full-year FY26 profit was ₹775 Cr. Over 10 years profit has grown 7.9% a year on average. That is 13.4% of the quarter's revenue. The same quarter a year earlier earned ₹164 Cr. For the full year, FY26 profit was ₹775 Cr (−3.5% on the year before). Why profit moved: revenue changed +14.9% on a year earlier and the margin moved −1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −10.6% and revenue +2.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Emami make, and is it growing? Emami Ltd reported ₹1,039 Cr of revenue in the Jun 2026 quarter, +14.9% on the same quarter a year earlier. Over 10 years it has grown 4.8% a year on average. The last full year, FY26, came in at ₹3,780 Cr. The last four reported quarters add to ₹3,915 Cr. FY26 revenue was ₹3,780 Cr, −0.8% on the year before. Recent pace: the last four quarters grew +2.6% on average, against 4.8% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +2.8%, against +3.5% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −8.2%, against +0.7% a year (rolling over). ## How much of every ₹100 of sales does Emami keep? Emami Ltd's operating margin was 22.0% in the Jun 2026 quarter, 1.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 25.0% and 31.0%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −1.9 percentage points on the year while gross margin changed −3.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Emami's profit turning into cash? Over the last 3 years, 108% of Emami Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹801 Cr of operating cash against ₹775 Cr of profit. After ₹65.0 Cr of spending on assets, ₹736 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 108% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Emami's cash go? Emami Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 8 days in FY26, down from 10 days in FY21. It spent ₹177 Cr on assets over the last 3 years. Customers take 33 days to pay, and stock sits for 128 days on average. At FY26 sales of ₹3,780 Cr, each day of that cycle ties up about ₹10.4 Cr, so roughly ₹83.0 Cr is tied up in the business at any time. FY26: customers took 33 days to pay and stock sat for 128 days, about 4.2 months of sales sitting as stock, for a full cycle of 8 days, shorter than FY21's 10. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 128 days. Customers pay about 33 days after that. Suppliers are paid at 153 days. Together that makes the 8-day cycle. Spending on assets: ₹177 Cr over the last 3 years, against ₹541 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹1.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Emami's P/E ratio, and how does it compare with its own history? Emami Ltd's P/E is 22.0×, near the low end of its own history: it has been lower only 6% of the time. Its usual P/E (the middle reading) is 42.2×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹17.15. Why the multiple is where it is: over the past year earnings per share moved −3.9% while the price moved −28.5%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −7.5% a year; about +6.7% a year came from earnings growth and about −14.2 percentage points from the multiple (the market paying less); over 10 years the price moved −4.4% a year; about +8.8% a year came from earnings growth and about −13.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Emami business getting better or worse? Emami Ltd's business is giving mixed signals. Profit and EPS growth are shrinking while ROCE is steady at 30.2%, so growth and returns point different ways. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Emami earn on its capital? Emami Ltd earned a ROCE of 28% in FY26. That is up from a low of 18% in FY20. Its return on capital used (ROIC) is 20.5 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 20.5% net margin and 0.99× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 20.5% net margin × 0.99× asset turnover × 1.31× leverage (assets divided by equity) ≈ 26.6% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 32.5% − 12.0% = +20.5 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. The 32.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 35.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Emami have too much debt? Emami Ltd has total debt of ₹162 Cr against shareholder equity of ₹2,922 Cr as of Jun 2026, so its debt is 0.06× its equity, which is very little. Year by year, that ratio went from 0.14 in FY22 to 0.06 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Emami shareholding pattern? Foreign institutions cut their stake in Emami Ltd by 5.4 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 9.0% of the company. Domestic institutions moved +2.1 points over the same period, to 23.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −5.4 points over 8 quarters, to 9.0%; Domestic institutions: +2.1 points over 8 quarters, to 23.6%; Promoters: +0.0 points over 8 quarters, to 54.8%. Why the owners changed: foreign institutions moved −5.4 points and domestic institutions +2.1 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Emami from balance-sheet trouble? For Emami Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Emami rank in its industry? 43.1 out of 100, rank 8 of 12 in FMCG - Personal Care, with 96% of the evidence available. Emami Ltd scores 43.1 out of 100 against the 12 companies it is compared with in FMCG - Personal Care, ranking 8. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 9 + 15.1 + 8.9 + 10.1 = 43.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Emami compared with? Emami ranks 8 of 12 FMCG - Personal Care companies on the 4-Factor Sector Score, with 43.1 out of 100. 1. [Bajaj Consumer Care Ltd](https://www.sectoralpha.in/stocks/bajaj-consumer-care-ltd) BAJAJCON · quiet · Most evidence points up · 100% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 28% · Profit 84.6% · Operating margin change 7 points · 100% evidence Capital efficiency 19.2/25 · ROCE 30% · Operating margin 25% · 100% evidence Valuation 11.7/20 · P/E 19.3× · PEG 1.64 · 100% evidence Relative strength 6.5/20 · Lead over its industry 0.2% · Lead over NIFTY 500 -10.2% · 1 year 33.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 19.2 + 11.7 + 6.5 = 70.1 · What this means: Earnings are strong; relative strength in its sector is 0.2% and the one-year return is 33.5%. 2. [Hindustan Unilever Ltd](https://www.sectoralpha.in/stocks/hindustan-unilever-ltd) HINDUNILVR · basing · Most evidence points up · 100% evidence 69.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 9.5% · Profit 38% · Operating margin change -2 points · 100% evidence Capital efficiency 15.8/25 · ROCE 28.4% · Operating margin 22% · 100% evidence Valuation 17.2/20 · P/E 39.1× · PEG 0.72 · 100% evidence Relative strength 12.8/20 · Lead over its industry 1% · Lead over NIFTY 500 -9.9% · 1 year -21% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.4 + 15.8 + 17.2 + 12.8 = 69.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Marico Ltd](https://www.sectoralpha.in/stocks/marico-ltd) MARICO · quiet · Most evidence points up · 78% evidence 66.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.4/35 · Revenue 25.1% · Profit 15% · Operating margin change 1 points · 83% evidence Capital efficiency 17.9/25 · ROCE 47% · Operating margin 21% · 76% evidence Valuation 6.8/20 · P/E 55.1× · PEG n/a · 50% evidence Relative strength 17.4/20 · Lead over its industry 18.9% · Lead over NIFTY 500 6.5% · 1 year 11.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 24.4 + 17.9 + 6.8 + 17.4 = 66.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) GILLETTE · turning · Evidence leans up · 81% evidence 64.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.0/35 · Revenue 8% · Profit 18.4% · Operating margin change -1 points · 88% evidence Capital efficiency 18.1/25 · ROCE 90.7% · Operating margin 29% · 100% evidence Valuation 13.6/20 · P/E 34.5× · PEG 1.7 · 100% evidence Relative strength 10.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -5.5% · 1 year -21.5% · 25% evidence · 0 of 12 weeks ahead Exact sum: 23 + 18.1 + 13.6 + 10.1 = 64.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) PGHH · basing · Evidence leans up · 81% evidence 52.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue -1.6% · Profit -4.7% · Operating margin change -9 points · 88% evidence Capital efficiency 17.6/25 · ROCE 157% · Operating margin 19% · 100% evidence Valuation 13.3/20 · P/E 28.1× · PEG 1.77 · 100% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -27.7% · 1 year -48.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.9 + 17.6 + 13.3 + 7.5 = 52.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 6. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) COLPAL · quiet · Evidence leans up · 85% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Revenue 8.7% · Profit 2.6% · Operating margin change -3 points · 100% evidence Capital efficiency 21.6/25 · ROCE 108% · Operating margin 28% · 100% evidence Valuation 8.4/20 · P/E 31.4× · PEG 6.07 · 100% evidence Relative strength 8.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -17.1% · 1 year -28.8% · 25% evidence · 0 of 12 weeks ahead Exact sum: 12.5 + 21.6 + 8.4 + 8.5 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Dabur India Ltd](https://www.sectoralpha.in/stocks/dabur-india-ltd) DABUR · basing · Evidence leans up · 81% evidence 51.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 7.4% · Profit 10.9% · Operating margin change 0 points · 88% evidence Capital efficiency 14.9/25 · ROCE 20.3% · Operating margin 20% · 100% evidence Valuation 9.1/20 · P/E 32.7× · PEG 5.04 · 100% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.7% · 1 year -25% · 25% evidence · 0 of 12 weeks ahead Exact sum: 18.2 + 14.9 + 9.1 + 8.8 = 51 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. Emami Ltd this page EMAMILTD · basing · Evidence leans down · 96% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.0/35 · Revenue 2.8% · Profit -8.2% · Operating margin change -1 points · 88% evidence Capital efficiency 15.1/25 · ROCE 28.1% · Operating margin 22% · 100% evidence Valuation 8.9/20 · P/E 20.7× · PEG 2.99 · 100% evidence Relative strength 10.1/20 · Lead over its industry -3.2% · Lead over NIFTY 500 -13.6% · 1 year -32.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 9 + 15.1 + 8.9 + 10.1 = 43.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Zydus Wellness Ltd](https://www.sectoralpha.in/stocks/zydus-wellness-ltd) ZYDUSWELL · quiet · Evidence leans down · 96% evidence 39.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 66.3% · Profit -42.5% · Operating margin change -1 points · 88% evidence Capital efficiency 7.9/25 · ROCE 4.9% · Operating margin 17% · 100% evidence Valuation 6.0/20 · P/E 66.5× · PEG 1.75 · 100% evidence Relative strength 12.7/20 · Lead over its industry 12.9% · Lead over NIFTY 500 1.1% · 1 year -2.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 12.8 + 7.9 + 6 + 12.7 = 39.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Godrej Consumer Products Ltd](https://www.sectoralpha.in/stocks/godrej-consumer-products-ltd) GODREJCP · quiet · Evidence leans down · 100% evidence 35.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 12.9% · Profit 8.6% · Operating margin change -1 points · 100% evidence Capital efficiency 10.3/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 4.3/20 · P/E 39.4× · PEG 7.49 · 100% evidence Relative strength 2.9/20 · Lead over its industry -8.6% · Lead over NIFTY 500 -18.5% · 1 year -26.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 10.3 + 4.3 + 2.9 = 35.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) JYOTHYLAB · quiet · Most evidence points down · 96% evidence 34.0 out of 100 Growth Capital Valuation Relative
12. [Polo Queen Industrial and Fintech Ltd](https://www.sectoralpha.in/stocks/polo-queen-industrial-and-fintech-ltd) PQIF · Too little evidence to rank firmly · 33% evidence 39.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [FMCG - Personal Care](https://www.sectoralpha.in/sectors/fmcg-personal-care), all 12 compared on one page. ## Which companies are close to Emami in size? Emami is the 8th largest of 12 FMCG - Personal Care companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Colgate-Palmolive (India), Gillette India and Procter & Gamble Hygiene and Health Care. Just below it: Zydus Wellness, Jyothy Labs and Bajaj Consumer Care. ### FMCG - Personal Care companies close in size

1. [Colgate-Palmolive (India) Ltd](https://www.sectoralpha.in/stocks/colgate-palmolive-indialtd) ₹43,423 crore
2. [Gillette India Ltd](https://www.sectoralpha.in/stocks/gillette-india-ltd) ₹23,064 crore
3. [Procter & Gamble Hygiene and Health Care Ltd](https://www.sectoralpha.in/stocks/procter-gamble-hygiene-and-health-care-ltd) ₹22,239 crore
4. Emami Ltd ₹15,703 crore
5. [Zydus Wellness Ltd](https://www.sectoralpha.in/stocks/zydus-wellness-ltd) ₹14,723 crore
6. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) ₹6,313 crore
7. [Bajaj Consumer Care Ltd](https://www.sectoralpha.in/stocks/bajaj-consumer-care-ltd) ₹4,835 crore

[All 12 FMCG - Personal Care companies, largest first](https://www.sectoralpha.in/sectors/fmcg-personal-care#all-companies)

### Companies close in size in other industries

1. [JSW Cement Ltd](https://www.sectoralpha.in/stocks/jsw-cement-ltd) ₹15,747 crore · Cement
2. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) ₹15,728 crore · Pesticides/Agrochemicals
3. Emami Ltd ₹15,703 crore
4. [Alembic Pharmaceuticals Ltd](https://www.sectoralpha.in/stocks/alembic-pharmaceuticals-ltd) ₹15,683 crore · Pharma - Formulators
5. [Sarda Energy & Minerals Ltd](https://www.sectoralpha.in/stocks/sarda-energy-minerals-ltd) ₹15,535 crore · Mining/Minerals - Iron Ore

## What else do people ask about Emami? ### What is Emami's share price today? Emami Ltd's share price is ₹382.00, −28.5% over the past year. The whole company is worth ₹16,663 Cr on the market. In the last 52 weeks it traded between ₹360 to ₹540; today it is 12% of the way up from the low, 10.0% below its 200-day average (as of 3 November 2026). ### What were Emami's latest quarterly results? Emami Ltd reported revenue of ₹1,039 Cr and net profit of ₹139 Cr for the Jun 2026 quarter. Revenue rose 14.9% and profit fell 15.2% compared with a year earlier. Earnings per share were ₹3.15. The operating margin was 22.0%, 1.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Emami's market cap? Emami Ltd's market capitalisation is ₹16,663 Cr at a share price of ₹382.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Emami performing? Emami Ltd's share price has been falling for 71 weeks. In its latest quarter, revenue rose 14.9% and profit fell 15.2% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 1 week running (as of 3 November 2026). ### Will Emami's share price go up? This page does not forecast Emami Ltd's share price. What it shows instead: the share price is ₹382.00, and it has been falling for 71 weeks. Its P/E of 22.0× is higher than 6% of its own last 11 years (as of 3 November 2026). ### Who owns Emami? Promoters own 54.8% of Emami Ltd, foreign institutions 9.0%, domestic institutions 23.6% and the public 12.6% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 5.4 percentage points over 8 quarters (as of 3 November 2026). ### Does Emami have too much debt? No, Emami Ltd has little debt: its debt is 0.06× its equity, and its operating profit is 87 times its interest bill. FY26 borrowings were ₹162 Cr against equity of ₹2,924 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is Emami in its business cycle? Emami Ltd's FY26 operating margin was 25.0%, against a 13-year range of 25.0% to 31.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 22.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Emami story? The main question: the P/E is near the low end of its own history, higher than only 6% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Emami a stock worth studying right now? What the numbers show: Emami Ltd's P/E is near the low end of its own history, higher than only 6% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Emami share price forecast for 2026? What management itself guided: Further pricing actions to more than offset the absolute input-cost increase during the financial year; productivity, procurement, and value-led revenue management to support margins. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india
- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india
- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.